SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

CDSO grants manufacturing license to Ambalal Sarabhai’s arm’s JV for Covid-19 RT-PCR test kits

28 Apr 2020 Evaluate

CoSara Diagnostics (CoSara), a Joint Venture (JV) company of Synbiotics, a wholly owned subsidiary of Ambalal Sarabhai Enterprises and CoDiagnostics Inc, USA, has been granted manufacturing license by Central Drugs Standard Control Organization (CDSO), Delhi to manufacture Saragenetm Covid ?19, RT?PCR test kits in India. The company has started to manufacture the test kits based upon the license granted at its Gujarat based plant. 

Ambalal Sarabhai Enterprises is engaged in manufacturing and marketing of pharmaceutical products, bulk drugs, industrial chemicals, detergents, toiletries, electronics, engineering products, paper, glass and plastic containers and packaging materials.

Ambalal Sarabhai Ent Share Price

33.09 1.30 (4.09%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×